Euglycaemic diabetic ketoacidosis in a patient with pancreatitis and type 2 diabetes on empagliflozin

被引:3
|
作者
Bardhi, Olgert [1 ]
Bloom, Matthew D. [1 ]
Sattari, Maryam [2 ]
机构
[1] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA
[2] Univ Florida, Internal Med, Gainesville, FL USA
关键词
Diabetes; Drugs; endocrine system; Medical management; INHIBITORS;
D O I
10.1136/bcr-2021-247921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sodium glucose cotransporter-2 (SGLT2) inhibitors are glucose-lowering drugs with proven efficacy in treating type 2 diabetes mellitus, and more recently, have been shown to improve heart failure outcomes in patients without diabetes. A rare complication of SGLT2 inhibitor use is the development of euglycaemic diabetic ketoacidosis (EDKA), characterised by euglycaemia (blood glucose level <250 mg/dL), metabolic acidosis (arterial pH <7.3 and serum bicarbonate <18 mEq/L), and ketonaemia. Given patients with EDKA do not present with the typical manifestations of diabetic ketoacidosis, including marked hyperglycaemia and dehydration, the diagnosis of EDKA may be missed and initiation of treatment delayed. We present the case of a man with recent SGLT2 inhibitor use and multiple other risk factors who developed EDKA.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] A ketone conundrum: Euglycaemic Diabetic Ketoacidosis in a patient with type 2 diabetes mellitus
    McCabe, G.
    Canavan, R.
    Salehmohamed, R.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S89 - S89
  • [2] Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes After Treatment With Empagliflozin
    Roach, Paris
    Skierczynski, Paul
    [J]. DIABETES CARE, 2016, 39 (01) : E3 - E3
  • [4] Euglycaemic diabetic ketoacidosis in a patient with gestational diabetes mellitus
    Hundia, V.
    Pettit, A.
    Eapen, D.
    [J]. DIABETIC MEDICINE, 2008, 25
  • [5] Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
    Chauhan, Sukhjinder
    Manov, Andrey, I
    Dhillon, Gundip S.
    Shah, Pinak
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [6] Euglycaemic diabetic ketoacidosis in a 43-year-old woman with type 2 diabetes mellitus on SGLT-2 inhibitor (empagliflozin)
    Latif, Azka
    Gastelum, Aheli Arce
    Sood, Akshat
    Reddy, Joseph Thilumala
    [J]. BMJ CASE REPORTS, 2020, 13 (06)
  • [8] Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
    Calcada, Marta Brandao
    Fernandes, Luis
    Soares Costa, Rita
    Montezinho, Sara
    Martins Duarte, Filipa
    Frutuoso, Luisa
    Freitas, Ana Raquel
    [J]. CLINICS AND PRACTICE, 2021, 11 (02) : 216 - 218
  • [9] Euglycaemic ketoacidosis in a patient with gestational diabetes
    Darbhamulla, Sudha
    Shah, Neil
    Bosio, Paul
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (01) : 118 - 119
  • [10] Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
    Albugami, Muneerah M.
    Ahmed, Mohammed
    Alobaid, Dhari
    [J]. SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2020, 8 (03): : 241 - 242